ArticleBreast cancer research and treatment2019

Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer.

Nicola J Camp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.